Phase III, randomised, double-blind, placebo-controlled trial of carmustine polifeprosan 20 wafer for new-diagnosed glioma and glioblastoma patients undergiong primary surgical resection.
Phase of Trial: Phase III
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Carmustine polifeprosan 20 wafer (Primary)
- Indications Glioblastoma; Glioma
- Focus Therapeutic Use
- Sponsors Nobelpharma
- 05 Nov 2010 New trial record.